Tokosi Temitope Oluwaseyi, Twum-Darko Michael
Graduate Centre for Management, Faculty of Business and Management Sciences, Cape Peninsula University of Technology, Cape Town, South Africa.
JMIR Res Protoc. 2021 Mar 19;10(3):e24589. doi: 10.2196/24589.
Mobile health crowdsensing (MHCS) involves the use of mobile communication technologies to promote health by supporting health care practices (eg, health data collection, delivery of health care information, or patient observation and provision of care). MHCS technologies (eg, smartphones) have sensory capabilities, such as GPS, voice, light, and camera, to collect, analyze, and share user-centered data (explicit and implicit). The current literature indicates no scientific study related to MHCS interventions for chronic diseases. The proposed systematic review will examine the impact of MHCS interventions on chronic disease awareness.
The objectives of this study are to identify and describe various MHCS intervention strategies applied to chronic disease awareness.
Literature from various databases, such as MEDLINE, Embase, PsycINFO, CINAHL, and Cochrane Central Register of Controlled Trials, will be examined. Trial registers, reports, grey literature, and unpublished academic theses will also be included. All mobile technologies, such as cell phones, personal digital assistants, and tablets that have short message service, multimedia message service, video, and audio capabilities, will be included. MHCS will be the primary intervention strategy. The search strategy will include keywords such as mHealth, crowdsensing, and awareness among other medical subject heading terms. Articles published from January 1, 1945, to December 31, 2019, will be eligible for inclusion. The authors will independently screen and select studies, extract data, and assess the risk of bias, with discrepancies resolved by an independent party not involved in the study. The authors will assess statistical heterogeneity by examining the types of participants, interventions, study designs, and outcomes in each study, and pool studies judged to be statistically homogeneous. In the assessment of heterogeneity, a sensitivity analysis will be considered to explore statistical heterogeneity. Statistical heterogeneity will be investigated using the chi-square test of homogeneity on Cochrane Q test, and quantified using the I statistic.
The preliminary search query found 1 paper. Further literature search commenced in mid-March 2021 and is to be concluded in April 2021. The proposed systematic review protocol has been registered in PROSPERO (The International Prospective Register of Systematic Reviews; no. CRD42020161435). Furthermore, the use of search data extraction and capturing in Review Manager version 5.3 (Cochrane) commenced in January 2021 and ended in February 2021. Further literature search will begin in mid-March 2021 and will be concluded in April 2021. The final stages will include analyses and writing, which are anticipated to start and be completed in May 2021.
The knowledge derived from this study will inform health care stakeholders-including researchers, policy makers, investors, health professionals, technologists, and engineers-of the impact of MHCS interventions on chronic disease awareness.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/24589.
移动健康众包感知（MHCS）涉及利用移动通信技术通过支持医疗保健实践（如健康数据收集、医疗保健信息传递或患者观察与护理提供）来促进健康。MHCS技术（如智能手机）具备诸如全球定位系统（GPS）、语音、光线和摄像头等传感能力，以收集、分析和共享以用户为中心的数据（显性和隐性）。当前文献表明尚无关于MHCS干预慢性病的科学研究。拟进行的系统评价将考察MHCS干预对慢性病认知的影响。
本研究的目的是识别和描述应用于慢性病认知的各种MHCS干预策略。
将检索多个数据库的文献，如医学主题词表（MEDLINE）、荷兰医学文摘数据库（Embase）、心理学文摘数据库（PsycINFO）、护理学与健康领域数据库（CINAHL）以及考克兰对照试验中心注册库。还将纳入试验注册库、报告、灰色文献和未发表的学术论文。所有具备短信服务、多媒体短信服务、视频和音频功能的移动技术，如手机、个人数字助理和平板电脑，均会被纳入。MHCS将作为主要干预策略。检索策略将包括“移动健康（mHealth） ”“众包感知”和“认知”等关键词以及其他医学主题词。1945年1月1日至2019年12月31日发表的文章符合纳入标准。作者将独立筛选和选择研究、提取数据并评估偏倚风险，如有分歧将由未参与该研究的独立第三方解决。作者将通过检查每项研究中的参与者类型、干预措施、研究设计和结果来评估统计异质性，并汇总判断为统计同质的研究。在异质性评估中，将考虑进行敏感性分析以探索统计异质性。将使用考克兰Q检验的卡方同质性检验来研究统计异质性，并使用I统计量进行量化。
初步检索查询找到1篇论文。进一步的文献检索于2021年3月中旬开始，将于2021年4月结束。拟进行的系统评价方案已在国际前瞻性系统评价注册库（PROSPERO；编号CRD42020161435）中注册。此外，2021年1月开始并于2021年2月结束了在Review Manager 5.3（考克兰）中使用搜索数据提取和捕获功能。进一步的文献检索将于2021年3月中旬开始并于2021年4月结束。最后阶段将包括分析和撰写，预计于2021年5月开始并完成。
本研究所得知识将使包括研究人员、政策制定者、投资者、卫生专业人员技术专家和工程师在内的医疗保健利益相关者了解MHCS干预对慢性病认知的影响。
国际注册报告识别码（IRRID）：PRR1-10.2196/24589。
